Personalized Medicine
13 videos · last 6 months shuffled daily, then older videos newest first
▶
29:49 Precision Medicine and Clinical Trials in Ovarian Cancer
Joyce Liu, MD, Director of Clinical Research in Gynecologic Oncology at Dana-Farber Cancer Institute, discusses precision medicine, targeted therapies and clinical trials in ovarian cancer, for Ovarcome.
▶
25:44 Precision Oncology in Lung Cancer with Boehringer Ingelheim’s Itziar Canamasas & Volker Teichgräber
Vera Kovacevic talks to Itziar Canamasas, PhD, Global Head of Oncology, and Volker Teichgräber, MD, Head of Global Experimental Medicine Oncology, both of Boehringer Ingelheim, about precision oncology in lung cancer.
▶
18:07 How Precision Oncology Is Redefining Cancer Drug Development with Aprea Therapeutics' Dr. Oren Gilad
Erin Harris talks to Dr. Oren Gilad, CEO of Aprea Therapeutics, about biomarker-driven drug development in difficult-to-treat solid tumours.
▶
3:14 ASPiRATION Genomic Profiling Study in Lung Cancer
TOGA updates the ASPiRATION study of comprehensive genomic profiling in metastatic NSCLC and its Phase II single-arm substudies, run with Omico and the NHMRC Clinical Trials Centre at the University of Sydney.
▶
3:48 n-Lorem Delivers HOPE to Treat Ultra-rare Diseases
The n-Lorem Foundation provides personalized antisense oligonucleotide (ASO) treatments to patients with ultra-rare diseases (1-30 patients, worldwide).
▶
5:44 Why Lung MAP Matters for MET Lung Cancer Patients
Marcia Horn of the International Cancer Advocacy Network on why Lung MAP matters for MET-driven lung cancer: three arms, each matching a patient's biomarker to a targeted therapy.
▶
4:42 Gene Editing Saves Baby with Rare Genetic Disease
9NEWS on a baby with a rare genetic disease who is thriving after an experimental gene editing treatment made specifically for him, one of the first such cases described in a new study.
▶
1:00:13 Designs of Precision Oncology Clinical Trials at the Markey Cancer Center
Heidi Weiss, PhD, on applying adaptive, Bayesian and basket trial designs to genomic and biomarker-driven oncology studies at the Markey Cancer Center.
▶
31:14 A Decade of LRRK2 and GBA1 Trials in Parkinson's
Aleks Pilcicka, Research Liaison Officer at Cure Parkinson's, gives an overview of recent clinical trials of therapies targeting LRRK2 and GBA1, two genetic risk factors for Parkinson's, at the 2025 Rallying to the Challenge meeting in Grand Rapids.
▶
4:37 Personalized mRNA Cancer Vaccine From Moderna
Moderna CEO discusses Phase 2 clinical trials by Moderna and Merck of a mRNA cancer vaccine showing "significant improvement" for melanoma when the mRNA vaccine used in combination with Keytruda.
▶
22:14 Dr. Razelle Kurzrock: N-of-1 Patient Centric Clinical Trials
Razelle Kurzrock, MD, on N-of-1 patient-centric clinical trials, in a video recorded at the Think Tank on Advancing Precision Medicine in Rare Cancers.
▶
56:39 From Drug Centric to Patient-Centric Precision Medicine & Immunotherapy Trials in Rare Cancers
A panel at TargetCancer Foundation's 2025 Think Tank on Advancing Precision Medicine in Rare Cancers on how trial designs are moving from one-size-fits-all to matching treatment to a patient's tumour biology.
▶
16:23 Ongoing Clinical Trials in Prostate Cancer
Daniel P. Petrylak, MD, of Yale University Cancer Center, reviews prostate cancer trials including talazoparib and lutetium PSMA, T-cell engagers JANX007 and AMG 509, and the NCI MATCH and PREDICT trials, for Grand Rounds in Urology.